Pharma Margin Pressure, Hospital Growth: HDFC Securities Q4 Outlook
HDFC Securities forecasts moderate revenue growth with flat EBITDA margins for India's pharma and healthcare sector in the March quarter. The pharma segment faces a 110 basis point margin contraction…